# AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

> **NCT07503210** · PHASE3 · RECRUITING · sponsor: **Novo Nordisk A/S** · enrollment: 600 (estimated)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** NNC0487-0111
- **DRUG:** Placebo (matched to NNC0487-0111)

## Key facts

- **NCT ID:** NCT07503210
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-21
- **Primary completion:** 2028-06-06
- **Final completion:** 2028-07-04
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07503210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07503210, "AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07503210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*